483 QuVa Pharma Aug 2003

483 QuVa Pharma Aug 2003

Stephen Beekman FDA, Daniel Lahar FDA$119.00 - Available Now

FDA investigators audited the QuVa Pharma - Temple, TX, United States facility and issued 6 inspectional observations (via FDA 483) on 22 Aug 2003.

Product details

  • Category: Human Drugs
  • Number of Observations: 6
  • Inspection end: 22 Aug 2003
  • Location: Temple, United States
  • FEI: 3002468086
Add To Cart